These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 32656264)

  • 21. Circular RNA Circ_0000064 promotes the proliferation and fibrosis of mesangial cells via miR-143 in diabetic nephropathy.
    Ge X; Xi L; Wang Q; Li H; Xia L; Cang Z; Peng W; Huang S
    Gene; 2020 Oct; 758():144952. PubMed ID: 32683074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noncoding RNAs and Stroke.
    Zhang X; Hamblin MH; Yin KJ
    Neuroscientist; 2019 Feb; 25(1):22-26. PubMed ID: 29637805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circular RNAs: An emerging precise weapon for diabetic nephropathy diagnosis and therapy.
    Shu H; Zhang Z; Liu J; Chen P; Yang C; Wu Y; Wu D; Cao Y; Chu Y; Li L
    Biomed Pharmacother; 2023 Dec; 168():115818. PubMed ID: 37939612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetic nephropathy--emerging epigenetic mechanisms.
    Kato M; Natarajan R
    Nat Rev Nephrol; 2014 Sep; 10(9):517-30. PubMed ID: 25003613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. REGULATORY ROLE OF NONCODING RNA IN SEPSIS AND SEPSIS-ASSOCIATED ORGAN DYSFUNCTION: AN UPDATED SYSTEMATIC REVIEW.
    Zhang T; Yang YH; Liu YP; Zhang TN; Yang N
    Shock; 2022 Nov; 58(5):434-456. PubMed ID: 36155389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of microRNAs in diabetic nephropathy.
    Wu H; Kong L; Zhou S; Cui W; Xu F; Luo M; Li X; Tan Y; Miao L
    J Diabetes Res; 2014; 2014():920134. PubMed ID: 25258717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RNA expression signatures and posttranscriptional regulation in diabetic nephropathy.
    Rudnicki M; Beckers A; Neuwirt H; Vandesompele J
    Nephrol Dial Transplant; 2015 Aug; 30 Suppl 4():iv35-42. PubMed ID: 26209736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long noncoding RNA: an emerging player in diabetes and diabetic kidney disease.
    Guo J; Liu Z; Gong R
    Clin Sci (Lond); 2019 Jun; 133(12):1321-1339. PubMed ID: 31221822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of Smad1 in diabetic nephropathy: Molecular mechanisms and implications as a diagnostic marker.
    Abe H; Matsubara T; Arai H; Doi T
    Histol Histopathol; 2011 Apr; 26(4):531-41. PubMed ID: 21360446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of Biomarkers and Molecular Therapy Based on Inflammatory Genes in Diabetic Nephropathy.
    Maiti AK
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exosomes: Advances, development and potential therapeutic strategies in diabetic nephropathy.
    Chen J; Zhang Q; Liu D; Liu Z
    Metabolism; 2021 Sep; 122():154834. PubMed ID: 34217734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long non-coding RNA MEG3 promotes fibrosis and inflammatory response in diabetic nephropathy via miR-181a/Egr-1/TLR4 axis.
    Zha F; Qu X; Tang B; Li J; Wang Y; Zheng P; Ji T; Zhu C; Bai S
    Aging (Albany NY); 2019 Jun; 11(11):3716-3730. PubMed ID: 31195367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Silencing of long noncoding RNA XIST protects against renal interstitial fibrosis in diabetic nephropathy via microRNA-93-5p-mediated inhibition of CDKN1A.
    Yang J; Shen Y; Yang X; Long Y; Chen S; Lin X; Dong R; Yuan J
    Am J Physiol Renal Physiol; 2019 Nov; 317(5):F1350-F1358. PubMed ID: 31545928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AGE/RAGE signaling-mediated endoplasmic reticulum stress and future prospects in non-coding RNA therapeutics for diabetic nephropathy.
    Pathomthongtaweechai N; Chutipongtanate S
    Biomed Pharmacother; 2020 Nov; 131():110655. PubMed ID: 32853909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long noncoding RNA growth arrest-specific transcript 5 alleviates renal fibrosis in diabetic nephropathy by downregulating matrix metalloproteinase 9 through recruitment of enhancer of zeste homolog 2.
    Zhang L; Zhao S; Zhu Y
    FASEB J; 2020 Feb; 34(2):2703-2714. PubMed ID: 31916627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pathological role of the ubiquitination pathway in diabetic nephropathy.
    Pontrelli P; Oranger A; Barozzino M; Conserva F; Papale M; Gesualdo L
    Minerva Med; 2018 Feb; 109(1):53-67. PubMed ID: 28974087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The topological key lncRNA H2k2 from the ceRNA network promotes mesangial cell proliferation in diabetic nephropathy
    Chen W; Peng R; Sun Y; Liu H; Zhang L; Peng H; Zhang Z
    FASEB J; 2019 Oct; 33(10):11492-11506. PubMed ID: 31336052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Noncoding RNAs in Atrial Fibrillation: Current Status and Prospect.
    Zhou D; Yang K; Hu J; Shi J; Hu X
    J Cardiovasc Pharmacol; 2020 Jan; 75(1):10-17. PubMed ID: 31895877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-coding RNAs in diabetic peripheral neuropathy: their role and mechanisms underlying their effects.
    He Y; Qu L
    Metabolism; 2024 May; 154():155833. PubMed ID: 38462040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-218 regulates diabetic nephropathy via targeting IKK-β and modulating NK-κB-mediated inflammation.
    Li M; Guo Q; Cai H; Wang H; Ma Z; Zhang X
    J Cell Physiol; 2020 Apr; 235(4):3362-3371. PubMed ID: 31549412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.